Volume 13 Issue 3
May  2022
Turn off MathJax
Article Contents
Chen Gang. Production and influence of donor specific antibodies after pediatric kidney transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(3): 303-306. doi: 10.3969/j.issn.1674-7445.2022.03.004
Citation: Chen Gang. Production and influence of donor specific antibodies after pediatric kidney transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(3): 303-306. doi: 10.3969/j.issn.1674-7445.2022.03.004

Production and influence of donor specific antibodies after pediatric kidney transplantation

doi: 10.3969/j.issn.1674-7445.2022.03.004
More Information
  • Corresponding author: Chen Gang, Email: gchentj@163.com
  • Received Date: 2022-02-05
    Available Online: 2022-04-29
  • Publish Date: 2022-05-15
  • In recent years, pediatric kidney transplantation has developed rapidly in China. However, clinical data related to the long-term survival of renal allografts are still lacking. The production of de novo donor specific antibody (dnDSA)and its mediated chronic rejection after adult kidney transplantation are pivotal risk factors affecting the long-term survival of renal allografts. Nevertheless, immune system in children has not fully developed. Hence, the production of dnDSA after kidney transplantation and its influence upon renal allografts and recipients might differ from those of adult. In this article, the characteristics of pediatric immune system, the production and influence of donor specific antibody (DSA) after pediatric kidney transplantation and the risk factors of the production of DSA after pediatric kidney transplantation were reviewed and certain suggestions were proposed for prevention strategies, aiming to provide reference for prolonging the long-term survival of renal allografts after pediatric kidney transplantation and promote the development of pediatric kidney transplantation in China.

     

  • loading
  • [1]
    WALDECKER CB, ZGOURA P, SEIBERT FS, et al. Biopsy findings after detection of de novo donor-specific antibodies in renal transplant recipients: a single center experience[J]. J Nephrol, 2021, 34(6): 2017-2026. DOI: 10.1007/s40620-021-01040-y.
    [2]
    LIU W, ZHAO J, KANG ZY, et al. De novo donor-specific HLA antibodies reduce graft survival rates and increase the risk of kidney transplant rejection: a single-center retrospective study[J]. Transpl Immunol, 2021, 68: 101430. DOI: 10.1016/j.trim.2021.101430.
    [3]
    DHARNIDHARKA VR, FIORINA P, HARMON WE. Kidney transplantation in children[J]. N Engl J Med, 2014, 371(6): 549-558. DOI: 10.1056/NEJMra1314376.
    [4]
    EVERLY MJ, BRILEY KP, HAISCH CE, et al. Racial differences in incident de novo donor-specific anti-HLA antibody among primary renal allograft recipients: results from a single center cohort study[J]. Transpl Int, 2017, 30(6): 566-578. DOI: 10.1111/tri.12937.
    [5]
    EVERLY MJ, REBELLATO LM, HAISCH CE, et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts[J]. Transplantation, 2013, 95(3): 410-417. DOI: 10.1097/TP.0b013e31827d62e3.
    [6]
    DEMIROK A, RANZIJN C, LARDY J, et al. Evaluation of the current post-transplantation human leukocyte antigen antibody screening in pediatric renal transplant recipients[J]. Pediatr Transplant, 2019, 23(2): e13338. DOI: 10.1111/petr.13338.
    [7]
    SHARMA A, TAVERNITI A, GRAF N, et al. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients[J]. Pediatr Nephrol, 2020, 35(6): 1061-1068. DOI: 10.1007/s00467-020-04474-x.
    [8]
    CIONI M, NOCERA A, INNOCENTE A, et al. De novo donor-specific HLA antibodies developing early or late after transplant are associated with the same risk of graft damage and loss in nonsensitized kidney recipients[J]. J Immunol Res, 2017: 1747030. DOI: 10.1155/2017/1747030.
    [9]
    GINEVRI F, NOCERA A, COMOLI P, et al. Posttransplant de novo donor-specific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection[J]. Am J Transplant, 2012, 12(12): 3355-3362. DOI: 10.1111/j.1600-6143.2012.04251.x.
    [10]
    CHARNAYA O, TUCHMAN S, MOUDGIL A. Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort[J]. Pediatr Transplant, 2018, 22(2): e13108. DOI: 10.1111/petr.13108.
    [11]
    FERNANDEZ HE. Application and interpretation of histocompatibility data in pediatric kidney transplantation[J]. Curr Opin Organ Transplant, 2017, 22(4): 426-432. DOI: 10.1097/MOT.0000000000000425.
    [12]
    FILIPPONE EJ, FARBER JL. The problem of subclinical antibody-mediated rejection in kidney transplantation[J]. Transplantation, 2021, 105(6): 1176-1187. DOI: 10.1097/TP.0000000000003543.
    [13]
    VELIDEDEOGLU E, CAVAILLÉ-COLL MW, BALA S, et al. Summary of 2017 FDA Public Workshop: antibody-mediated rejection in kidney transplantation[J]. Transplantation, 2018, 102(6): e257-e264. DOI: 10.1097/TP.0000000000002141.
    [14]
    VO AA, AUBERT O, HAAS M, et al. Clinical relevance of posttransplant DSAs in patients receiving desensitization for HLA-incompatible kidney transplantation[J]. Transplantation, 2019, 103(12): 2666-2674. DOI: 10.1097/TP.0000000000002691.
    [15]
    KONVALINKA A, TINCKAM K. Utility of HLA antibody testing in kidney transplantation[J]. J Am Soc Nephrol, 2015, 26(7): 1489-1502. DOI: 10.1681/ASN.2014080837.
    [16]
    TAFULO S, MALHEIRO J, SANTOS S, et al. HLA class Ⅱ eplet mismatch load improves prediction of dnDSA development after living donor kidney transplantation[J]. Int J Immunogenet, 2021, 48(1): 1-7. DOI: 10.1111/iji.12519.
    [17]
    AHLENSTIEL-GRUNOW T, PAPE L. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation[J]. Pediatr Nephrol, 2020, 35(3): 375-382. DOI: 10.1007/s00467-018-4164-3.
    [18]
    TANNÉ C, ROY P, FROBERT É, et al. Cytomegalovirus infection in the first year after pediatric kidney transplantation[J]. Nephrol Ther, 2019, 15(1): 44-50. DOI: 10.1016/j.nephro.2018.04.003.
    [19]
    TSAMPALIEROS A, KNOLL GA, MOLNAR AO, et al. Corticosteroid use and growth after pediatric solid organ transplantation: a systematic review and Meta-analysis[J]. Transplantation, 2017, 101(4): 694-703. DOI: 10.1097/TP.0000000000001320.
    [20]
    STROMMEN AM, MOSS MC, GOEBEL J, et al. Donor-specific antibodies in a pediatric kidney transplant population-prevalence and association with antiproliferative drug dosing[J]. Pediatr Transplant, 2019, 23(6): e13511. DOI: 10.1111/petr.13511.
    [21]
    HOEGY D, BLEYZAC N, ROBINSON P, et al. Medication adherence in pediatric transplantation and assessment methods: a systematic review[J]. Patient Prefer Adherence, 2019, 13: 705-719. DOI: 10.2147/PPA.S200209.
    [22]
    GAJARDO M, DELUCCHI A, PÉREZ D, et al. Long-term outcome of early steroid withdrawal in pediatric renal transplantation[J]. Pediatr Transplant, 2021, 25(8): e14096. DOI: 10.1111/petr.14096.
    [23]
    SHEN Q, FANG X, MAN X, et al. Pediatric kidney transplantation in China: an analysis from the IPNA Global Kidney Replacement Therapy Registry[J]. Pediatr Nephrol, 2021, 36(3): 685-692. DOI: 10.1007/s00467-020-04745-7.
    [24]
    LIU L, ZHANG H, FU Q, et al. Current status of pediatric kidney transplantation in China: data analysis of Chinese Scientific Registry of Kidney Transplantation[J]. Chin Med J (Engl), 2014, 127(3): 506-510.
    [25]
    陈刚. 中国儿童肾移植的现状及对未来发展的思考[J]. 中华器官移植杂志, 2020, 41(1): 1-2. DOI: 10.3760/cma.j.issn.0254-1785.2020.01.001.

    CHEN G. Current situation of renal transplantation in children in China and its future development[J]. Chin J Organ Transplant, 2020, 41(1): 1-2. DOI: 10.3760/cma.j.issn.0254-1785.2020.01.001.
    [26]
    CHARNAYA O, JONES J, PHILOGENE MC, et al. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients[J]. Pediatr Nephrol, 2020, 36(12): 3971-3979. DOI: 10.1007/s00467-021-05078-9.
    [27]
    SYPEK MP, HIHO S, CANTWELL L, et al. Human leukocyte antigen eplet mismatches and long-term clinical outcomes in pediatric renal transplantation: a pragmatic, registry-based study[J]. Pediatr Transplant, 2020, 24(4): e13705. DOI: 10.1111/petr.13705.
    [28]
    KAUSMAN JY, WALKER AM, CANTWELL LS, et al. Application of an epitope-based allocation system in pediatric kidney transplantation[J]. Pediatr Transplant, 2016, 20(7): 931-938. DOI: 10.1111/petr.12815.
    [29]
    LARKINS NG, WONG G, TAVERNITI A, et al. Epitope matching in kidney transplantation: recent advances and current limitations[J]. Curr Opin Organ Transplant, 2019, 24(4): 370-377. DOI: 10.1097/MOT.0000000000000657.
    [30]
    CHANDAR J, CHEN L, DEFREITAS M, et al. Donor considerations in pediatric kidney transplantation[J]. Pediatr Nephrol, 2021, 36(2): 245-257. DOI: 10.1007/s00467-019-04362-z.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (392) PDF downloads(107) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return